LISCure Biosciences receives U.S. FDA Fast Track designation for LB-P8 for the treatment of primary sclerosing cholangitis (PSC)
Phase 2 study is underway and LB-P8 is the only live biotherapeutic product currently reported to be in clinical development for the treatment of PSC FDA's Fast Track designation for LB-P8 under...
- March 30, 2024 12:00 AM AEDT
- Cision
Aohua receives Endoscopy Award at Healthcare Asia Medtech Awards 2024
SINGAPORE, March 29, 2024 /PRNewswire/ -- At the most recent Healthcare Asia Medtech Awards 2024, Aohua Endoscopy, a medical equipment manufacturer, won the Endoscopy Product Innovation Award for...
- March 30, 2024 12:00 AM AEDT
- Cision